drugset / Trial / NCT05956769

Goal-directed vs Preemptive Tranexamic Acid Administration in Total Hip Arthroplasty

NCT05956769 ↗

Unknown 84 enrolled Konkuk University Medical Center
RandomizedParallel-groupQuadruple-blindDiagnostic

Summary

The present study is a multi-center randomized prospective placebo-controlled non-inferiority trial. The study's primary objective is to compare the amounts of postoperative bleeding using two different TXA administration strategies: empirical TXA administration vs. viscoelastic test-based Goal-directed vs Preemptive Tranexamic Acid Administration in total hip arthroplasty. The secondary objectives include comparing the incidents of hyper-fibrinolysis, thromboembolic complications, and postoperative seizures. Researchers assumed that goal-directed tranexamic acid (TXA) administration using viscoelastic field tests would not be inferior to the empirical TXA administration strategy in reducing postoperative bleeding and hyper-fibrinolysis. It also would be beneficial in lowering TXA-induced thromboembolic complications and seizures.

Timeline

Start
2024-02-01
Primary completion
2024-11-30
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 2 mg/kg —

Indications

No indication recorded.